Purchase Order N0025919P0511
Award Date
9/27/19
Potential Completion Date
9/30/20
Potential Value
$140K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Karius, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Karius, Inc. for quantitative next-generation sequencing testing services. The $240,000 contract supports DHA programs through September 2023 and leverages Karius' expertise in genomic sequencing to rapidly screen patients for various pathogens. This is a sole source award, as Karius is the only commercial laboratory capable of providing the requested cell-free DNA testing from plasma samples with 24-72...
This federal contract award is to Karius, Inc., a life sciences company specializing in diagnostic science and technology for infectious diseases. The $240,000.00 Purchase Order contract is for the provision of a Quantitative Next-Gen Sequencing Test to the Defense Health Agency, a defense agency. The contract has a period of performance through September 30, 2027 and was awarded on a Firm Fixed Price basis without any set-aside designation. Karius, Inc. has secured multiple prior federal...
The Defense Health Agency (DOD) awarded a $250,000 firm fixed price purchase order to Karius, Inc., doing business as Karius Inc., located in San Diego, California. The contract is for Quantitative Next-Gen Sequencing Testing Services and has a period of performance from October 1, 2022 through September 30, 2023. Karius provides genomic sequencing and bioinformatics analysis services to identify pathogens and monitor antimicrobial resistance. No applicable subcontractors were identified in...
This is a Delivery Order contract awarded to Karius, Inc. by the Department of Veterans Affairs Veterans Health Administration (VA VHA), with a ceiling value of $55,000.00. The contract is for Karius' provision of specialized molecular diagnostic testing and next-generation sequencing (NGS) services, including quantitative genomic testing to rapidly identify pathogens and monitor antimicrobial resistance. The contract has no set-aside designation, indicating Karius is competing as a standard...
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 has awarded Karius, Inc. a firm-fixed-price delivery order contract for its Karius Next Generation Sequencing (NGS) diagnostic test. The contract has a ceiling value of $60,000 and a performance period from August 1, 2023 to July 31, 2024. This award is part of a larger $600,000 Indefinite Delivery Contract (IDC) that Karius holds with the VA VHA, which has an ultimate completion date of July 31, 2027. The...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Karius, Inc. for the provision of next-generation sequencing (NGS) tests. The contract, valued at $120,000.00, has an ultimate completion date of July 31, 2025. Karius, Inc. is the sole source provider of these specialized NGS tests for the VA VHA, as the agency determined the company to be the only responsible source capable of meeting its requirements. This...
This is a $630,976 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Karius, Inc., a life sciences company headquartered in Redwood City, California. The contract is for research and development of metagenomic sequencing of microbial cell-free DNA and RNA for comprehensive pathogen detection. Karius, Inc. is a specialized provider of advanced molecular diagnostic testing and next-generation...
This is a $99,996.96 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract is for the delivery of Illumina's RNA Prep with Enrichment kits, MiSeq reagent kits, respiratory virus oligo panels, and DNA/RNA universal dual (UD) indexes to support genomic sequencing and analysis requirements at the Naval Health Research Center in San Diego, California....
This firm fixed-price purchase order contract was awarded by the Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $98,450.40, is to provide the agency with TruSeq Nano DNA Kits and MiSeq Reagent Kit V2 for genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract worth up to $3.3 million that supports the Navy's nucleic acid...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the provision of reagents and lab supplies. The award, valued at $161,614.14, is not associated with a set-aside program. The reagents and supplies are intended to support nucleic acid sequencing needs of the Naval Medical Research Center's Biological Defense Research Directorate for characterizing biological threats....